Concepedia

Publication | Open Access

Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma

DOIFull Paper Access

100

Citations

23

References

2015

Year

Philipp Kickingereder, Benedikt Wiestler, Sina Burth, Antje Wick, Martha Nowosielski, Sabine Heiland, Heinz-Peter Schlemmer, Wolfgang Wick, Martin Bendszus, Alexander Radbruch
Neuro-Oncology

Abstract

Pretreatment rCBV is a potential predictive imaging biomarker in BEV-treated rGB but not alkylating chemotherapy-treated rGB, which is superior to volumetric analysis of conventional anatomic MRI and predicts 6-month PFS and 12-month OS in 80% of BEV-treated patients.

References

YearCitations

Page 1